| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000043902 |
| Receipt No. | R000050138 |
| Scientific Title | Examination of bowel movement improving effect of yogurt |
| Date of disclosure of the study information | 2021/12/31 |
| Last modified on | 2021/07/08 (Ver. 4) |
| Basic information | ||
| Public title | Examination of bowel movement improving effect of yogurt | |
| Acronym | Examination of bowel movement improving effect of yogurt | |
| Scientific Title | Examination of bowel movement improving effect of yogurt | |
| Scientific Title:Acronym | Examination of bowel movement improving effect of yogurt | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Ingest yogurt for 2 weeks in adult men and women who are aware of constipation, and examine whether or not there is improvement in bowel movements after ingestion. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Compare the number of defecations in the week before ingestion with the number of defecations in the week from 1 week after ingestion to 2 weeks after ingestion. |
| Key secondary outcomes | Compare the stool properties for 1 week before ingestion with the stool properties for 1 week from 1 week after ingestion to 2 weeks after ingestion. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake yogurt for 2 weeks | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Subjects who have received sufficient explanation about the purpose and contents of this examination, have the ability to consent, fully volunteered with voluntary intention, agreed to participate in the document.
(2) Subjects with an average of 4 or less bowel movements per week. (3) Subjects who have agreed to account registration for the smartphone app "Unlog", subjects who have already registered for an account. |
|||
| Key exclusion criteria | (1) Subjects with chronic medical illness or a history of serious illness.
(2) Subjects with underlying disease that causes chronic constipation, subjects with a history of gastrointestinal surgery. (3) Subjects who do not have a dietary habit of 3 meals a day. (4) Subjects with food allergies. (5) Subjects with lactose intolerance. (6) Subjects who took fermented milk such as yogurt, lactic acid bacteria drink, and natto at least 4 times a week during the month before the SCR test. (7) Subjects taking medications or quasi-drugs that may affect the study at least once a week, or subjects taking health foods at least four times a week, or subjects taking health foods four or more times a week during the month prior to the SCR test, or Subjects who plan to use these at least once during the study. (8) Subjects who have undergone gastroscopy, gastric X-ray barium, colonoscopy, colon cleansing or stool removal during the month prior to SCR, or during this study. (9) Subjects with or may have or have a history of IBS / organic constipation. (10) Subjects who participated in or plan to participate in other studies except observational studies during the month prior to the SCR test. (11) Women with changes in bowel movements during menstruation. (12) Pregnant subjects, subjects planning to become pregnant during the study period. (13) Breastfeeding subjects. (14) Smokers or subjects who quit smoking for less than 3 months. (15) Subjects who drink much alcohol. (16) Subjects who plan to move with night shifts or accommodation. (17) Subjects who are judged as ineligible by the clinical investigator. |
|||
| Target sample size | 22 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Urban heights clinic | ||||||
| Division name | None | ||||||
| Zip code | 170-0002 | ||||||
| Address | 1-16-2 sugamo, toshima-ku, Tokyo, Japan | ||||||
| TEL | 03-3946-6721 | ||||||
| ucl6721@sepia.ocn.ne.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | EP Mediate Co., Ltd. | ||||||
| Division name | Development Business Headquarters, TTC Center, Trial Planning Department | ||||||
| Zip code | 162-0822 | ||||||
| Address | Tsuruya Bldg., 2-23 Shimomiyabicho, Shinjuku-ku, Tokyo | ||||||
| TEL | 03-5657-4983 | ||||||
| Homepage URL | |||||||
| tsuji472@eps.co.jp | |||||||
| Sponsor | |
| Institute | EP Mediate Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Meiji Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Medical Station Clinic Research Ethics Committee |
| Address | 3-12-8, Takaban, Meguroku, Tokyo |
| Tel | 03-6452-2712 |
| saito876@eps.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人社団 絆 アーバンハイツクリニック/Urban heights clinic |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050138 |